A naukri.com initiative
Bloomberg Quint
1d
11
Image Credit: Bloomberg Quint
Aurobindo Pharma Q4 Results: Profit Stays Flat, Misses Estimates
- Aurobindo Pharma's Q4 profit remains nearly unchanged, falling short of analysts' projections.
- The company's margin decreased to 21.4% from 22% in the previous year.
- Quarterly revenue increased by 10.6% to Rs 8,382 crore.
- Factors impacting the net profit included higher interest costs, depreciation expenses, and increased taxes.
Read Full Article
Like
For uninterrupted reading, download the app